- Home
- FOFO vs CRIS Comparison
FOFO vs CRIS Comparison
Compare FOFO & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FOFO | CRIS |
|---|---|---|
| Founded | 2017 | 2000 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2M | 20.6M |
| IPO Year | 2025 | 2000 |
Fundamental Metrics
Financial Performance| Metric | FOFO | CRIS |
|---|---|---|
| Price | $2.15 | $1.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 5.2K | ★ 296.4K |
| Earning Date | 03-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | $27.10 |
| Revenue Next Year | N/A | $67.74 |
| P/E Ratio | $11.09 | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $1.75 | $0.18 |
| 52 Week High | $68.00 | $6.74 |
Technical Indicators
Market Signals| Indicator | FOFO | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 25.80 |
| Support Level | $1.79 | $0.80 |
| Resistance Level | $2.70 | $1.42 |
| Average True Range (ATR) | 0.15 | 0.12 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 6.38 | 7.94 |
Price Performance
Historical ComparisonAbout FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their business and investment objectives. Its business consists of two main business lines: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting and Regulatory compliance and governance consulting, and the asset management services, including fund subscription and fund management services.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.